跳至主要内容
临床试验/IRCT138711131630N1
IRCT138711131630N1已完成3 期

Effect of atorvastatin on the incidence of atrial fibrillation in patients undergoing coronary artery bypass graft surgery

Shiraz University of Medical Sciences0 个研究点目标入组 150 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
已完成
入组人数
150

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
no limit 至 no limit(—)
性别
All

入选标准

  • Patients undergoing isolated coronary artery bypass graft surgery. Exclusion criteria: 1. History of atrial fibrillation; 2. Renal failure with plasma creatinine greater than 2 mg/dl; 3. Malignant or inflammatory diseases; 4. Routine use of atorvastatin; 5. Mixed cardiac operations including valve replacement; 6. Using antiarrhythmic drugs except beta-blockers; 7. Active hepatic-biliary diseases; 8. Increase in serum transaminases with undetermined cause; 9. Patients re-operated because of bleeding or other complications of surgery; 10. Glucocorticoids use.

排除标准

  • 未提供

研究者

相似试验